Amarin, Omthera dip after study knocks fish oil benefit
A large study showing heart patients failed to benefit from taking fish oil supplements, nicked the shares of two US companies that are focused on prescription-strength medicines.
A large study showing heart patients failed to benefit from taking fish oil supplements, nicked the shares of two US companies that are focused on prescription-strength medicines.